157 related articles for article (PubMed ID: 9552416)
1. Aberrations of the G1- and G1/S-regulating genes in human cancer.
Bartkova J; Lukas J; Bartek J
Prog Cell Cycle Res; 1997; 3():211-20. PubMed ID: 9552416
[TBL] [Abstract][Full Text] [Related]
2. Control of the G1/S transition.
Reed SI
Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell cycles.
Sherr CJ
Science; 1996 Dec; 274(5293):1672-7. PubMed ID: 8939849
[TBL] [Abstract][Full Text] [Related]
4. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
5. CycD1, a putative G1 cyclin from Antirrhinum majus, accelerates the cell cycle in cultured tobacco BY-2 cells by enhancing both G1/S entry and progression through S and G2 phases.
Koroleva OA; Tomlinson M; Parinyapong P; Sakvarelidze L; Leader D; Shaw P; Doonan JH
Plant Cell; 2004 Sep; 16(9):2364-79. PubMed ID: 15316112
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of the G1/S-phase control in human testicular germ cell tumours.
Bartkova J; Rajpert-De Meyts E; Skakkebaek NE; Lukas J; Bartek J
APMIS; 2003 Jan; 111(1):252-65; discussion 265-6. PubMed ID: 12760379
[TBL] [Abstract][Full Text] [Related]
8. Genetic instability as a consequence of inappropriate entry into and progression through S-phase.
Almasan A; Linke SP; Paulson TG; Huang LC; Wahl GM
Cancer Metastasis Rev; 1995 Mar; 14(1):59-73. PubMed ID: 7606822
[TBL] [Abstract][Full Text] [Related]
9. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
[TBL] [Abstract][Full Text] [Related]
11. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
12. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
13. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
14. Pathways governing G1/S transition and their response to DNA damage.
Bartek J; Lukas J
FEBS Lett; 2001 Feb; 490(3):117-22. PubMed ID: 11223026
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of pRb2/p130 interaction with cyclins.
Claudio PP; De Luca A; Howard CM; Baldi A; Firpo EJ; Koff A; Paggi MG; Giordano A
Cancer Res; 1996 May; 56(9):2003-8. PubMed ID: 8616840
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Lukas J; Aagaard L; Strauss M; Bartek J
Cancer Res; 1995 Nov; 55(21):4818-23. PubMed ID: 7585513
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
19. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
Foster JS; Wimalasena J
Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclin D1 overexpression on G1 progression-related events.
Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
